medline.ch Dermatologie Psoriasis

	Microbiome-Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics. Immun Inflamm Dis Sharma P, Nhokwara T, Singh J, Bala K, Kamra K. PMID: 42958627 [PubMed - indexed for MEDLINE]
	Response to correspondence on 'Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials' by Annfeldt et al. Ann Rheum Dis Annfeldt TK, Haugegaard T, Coates LC, Orbai AM, Leung YY, Christensen R. PMID: 42957384 [PubMed - in process]
	Difficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry. Semin Arthritis Rheum Elsehrawy GG, Courvoisier DS, Brülhart-Bletsas L, Dan D, Lazarou I, Micheroli R, Ciurea A, Scholz GA, Möller B, Nissen MJ. PMID: 42956546 [PubMed - as supplied by publisher]
	Psoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden. Cureus Tomlinson P, Sauers KN, Nosal E, Davies B, McGarvey CE, Stackhouse J. PMID: 42953876 [PubMed]
	Correction: Long-term comorbidities and mortality associations with treatment in generalized pustular psoriasis: a multi-institutional cohort study. Front Immunol Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. PMID: 42953532 [PubMed - in process]
	Associations of glucose- and lipid-lowering medications with incident or first-recorded psoriasis: a systematic review of real-world observational studies. Front Pharmacol Li Z, Yang J, Chen D. PMID: 42953016 [PubMed]
	Selected adverse events during the 12-week induction period of a phase III trial of vunakizumab: an exploratory post-hoc analysis. Front Immunol Wei Z, Xu L, Wang A. PMID: 42952621 [PubMed - indexed for MEDLINE]
	Realâ€‘world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial. Ann Rheum Dis Ruscitti P, Masedu F, Pantano I, Annunziata M, Berardicurti O, Celletti E, Ciaffi J, Cipriani C, Corrado A, Costa L, Dionisi A, Di Penta M, Gandolfo S, La Barbera L, Lo Gullo A, Mariani FM, Mauro D, Mellone M, Navarini L, Oliva M, Raimondi M, Ricciardi RM, Saracino F, Sgarlata G, Simone A, Shariat Panahi A, Tasso M, Tragni D, Vallocchia L, Venafro F, Viapiano F, Valenti M, Cantatore FP, Favoino E, Prete M, Racanelli V, Perosa F, Ursini F, Caso F, Cipriani P, Caporali R, Scarpa R, Giacomelli R, Ciccia F, Guggino G, GIRRCS study group. PMID: 42951730 [PubMed - as supplied by publisher]
	Real-World 52-Week Effectiveness of Tildrakizumab for Psoriasis: Analysis Stratified by Age, Disease Duration, and Body Mass Index. J Nippon Med Sch Okabe Y, Hagino T, Saeki H, Kanda N. PMID: 42951593 [PubMed - indexed for MEDLINE]
	Multidisciplinary Delphi Consensus on Psoriatic Patients with Cancer Who Benefit from Biologic Therapy: Key Nodes and Referral Letter. J Am Acad Dermatol Raimondo A, Balato A, Formisano L, Guarneri C, Megna M, Musumeci ML, Napolitano S, Sabbatino F, Lembo S, Panellists of the . PMID: 42950991 [PubMed - as supplied by publisher]
	The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET). Arthritis Rheumatol Eder L, Ribeiro AL, de Toledo RA, Bakewell C, Carron P, Elnady B, Haddad A, Kavanaugh A, Katz A, Kohler MJ, Marin J, Afgani F, Malliotis N, Nguyen N, Nzeusseu A, Polachek A, Rodriguez E, Rosemffet M, Singh A, Stoenoiu MS, Szentpetery A, Tinazzi I, Yinh J, Yang M, McGonagle D, Cook R, Kaeley GS, Aydin SZ. PMID: 42949213 [PubMed - as supplied by publisher]
	Effect of rosuvastatin as add-on to standard treatment on disease severity, inflammatory, and angiogenic biomarkers in chronic plaque psoriasis patients having cardiovascular risk: A nonrandomized, assessor blind, controlled clinical trial (RoSInA-P3 trial). Perspect Clin Res Siwach S, Mittal N, Dayal S, Goel N, Asija M, Mishra A. PMID: 42948521 [PubMed]
	Integrated Single-Cell Transcriptomics, Multi-Omics, and Mendelian Randomization Reveal Ferroptosis-Related Molecular Subtypes and a Genetically Supported Causal Candidate in Psoriasis. Clin Cosmet Investig Dermatol Xu M, Zuo Y, Liu H, Jia H, Liu X. PMID: 42948308 [PubMed]
	Vitamin D status and systemic inflammatory burden as a predictor of biologic treatment response in psoriasis -A pilot study in Northern Ireland. Clin Exp Dermatol Rahman KL, McKenna K, Kearney N, McCann M, Rodriguez EP, Demirdijan SP, Thompson P. PMID: 42947505 [PubMed - as supplied by publisher]
	Tumor necrosis factor inhibitors and cardiovascular outcomes in adults with moderate-to-severe plaque psoriasis: a systematic review and meta-analysis. An Bras Dermatol Mesa Rodríguez LF, Zambrano Aristizábal A, Vega Padilla JD. PMID: 42945615 [PubMed - as supplied by publisher]
	Topical Vitamin D Analogs Beyond Psoriasis: Pharmacological Mechanisms, Cutaneous Drug Delivery, and Clinical Evidence. Pharmaceutics Laçej D, Pietrella A, Zoratto N, Lombardi M, Di Meo C, Matricardi P. PMID: 42942780 [PubMed]
	The Skin-Bone Axis in Psoriasis: An Emerging Osteoimmunological Perspective. J Clin Med Saito-Sasaki N, Sawada Y. PMID: 42941578 [PubMed]
	Psoriasis and Bullous Pemphigoid: An Updated Review of Clinical Association, Targeted Therapy Exposures and Therapeutic Implications. Biomolecules Cui S, Zhang B, Li L. PMID: 42939646 [PubMed - indexed for MEDLINE]
	Prospective Study of Efficacy, Safety, and Predictors of Response to Deucravacitinib in Chinese Patients with Moderate-to-Severe Plaque Psoriasis. Psoriasis (Auckl) Dong C, Wang Y, Sun J, Lin JM, Lu X, Zhu J, Lin L, Zhu X, Huang H, Xu J, Wu W, Du J. PMID: 42936288 [PubMed]
	Epidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence. Diabetes Metab Res Rev Wang J, Zhou X, Chen J, Wang Q, Yi X, Gao P, He J, Yang S, Zhang M, Sun X, Liu L, Li X. PMID: 42935224 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 28714

Seite 1 von 1436

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung